Get in touch

Latest Updates

News, Stories & Healthcare Insights

Tiefenbacher Group - Four adults stand outdoors holding hands and smiling in a bright, cheerful setting with green trees. The "Tiefenbacher Pharmaceuticals" logo appears in the upper left, highlighting expertise in pharmaceutical healthcare solutions.
  • News

Tiefenbacher marks World Cancer Day 2023

TIEFENBACHER marks ‘World Cancer Day 2023’ to increase awareness prevention throughout media togetherTIEFENBACHER joined to harness the power of social media to raise awareness on cancer early detection and...

Tiefenbacher Group - A black play button icon, symbolizing API distribution, is centered on a plain white background.
Tiefenbacher Group - A white play button icon centered within a blue hexagon on a light gray background, representing pharmaceutical healthcare solutions.
  • News

Tiefenbacher Group wishes a happy Chinese New Year 2023!

We at Tiefenbacher Group appreciate the diversity of our colleagues very much and are happy to celebrate their local traditions together. This year, on the 22nd of January, people...

Tiefenbacher Group - A black play button icon, symbolizing API distribution, is centered on a plain white background.
Tiefenbacher Group - A white play button icon centered within a blue hexagon on a light gray background, representing pharmaceutical healthcare solutions.
  • News

Tiefenbacher Group wishes a healthy New Year 2023

From all over the world, we wish you a happy and healthy New Year 2023!Tiefenbacher Group wishes a everyone a healthy New Year. We hope the year 2023 will...

Tiefenbacher Group - A smiling woman in a green top and backpack stands with arms outstretched before lush mountains and fields. The logo and text "Tiefenbacher Pharmaceuticals" highlights their pharmaceutical healthcare solutions in the upper right corner.
  • News

Tiefenbacher Pharmaceuticals New Market Launch: Apremilast (Psoriasis)

New Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the psoriasis medication Apremilast in CanadaWe at Tiefenbacher Pharmaceuticals strive to make our high-quality medicines better affordable and better...

Tiefenbacher Group - An older man with gray hair smiles while sitting on a couch, wearing a light gray shirt. The logo and name "AET Tiefenbacher Pharmaceuticals," a family-owned pharmaceutical company, is visible in the upper right corner.
  • News

Tiefenbacher Pharmaceuticals New Market Launch: Abiraterone for prostate cancer

New Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launces generic version of the prostate cancer medicines Abiraterone and the value-added product Abiraterone/PrednisoloneWe at Tiefenbacher Pharmaceuticals aim to improve peoples´ lives around...

Tiefenbacher Group - A black play button icon, symbolizing API distribution, is centered on a plain white background.
Tiefenbacher Group - A white play button icon centered within a blue hexagon on a light gray background, representing pharmaceutical healthcare solutions.
  • News

Thanks for visiting us at CPhI 2022 in Frankfurt!

Tiefenbacher Group: Three Successful Days at CPhI 2023 – Thank you for visiting us in Barcelona! CPHI 2022, the world`s leading pharma event, has just come to an end....

Tiefenbacher Group - A black play button icon, symbolizing API distribution, is centered on a plain white background.
Tiefenbacher Group - A white play button icon centered within a blue hexagon on a light gray background, representing pharmaceutical healthcare solutions.
  • News

TIEFENBACHER GROUP opens new manufacturing site in Cyprus

TIEFENBACHER GROUP opens new manufacturing site in Cyprus for drug production of high-quality pharmaceuticals – we continuously expand in novel technologies and capabilities to improve quality and boost productivity....

Tiefenbacher Group - OYSTA logo beside a medical device showing "10 mg" and a smartphone displaying the OYSTA app for mood tracking, dosage management, and health logs—highlighting patient-centric drug development in pharmaceutical healthcare solutions.
  • News

TIEFENBACHER GROUP and OnDosis launch the innovative healthcare brand OYSTA®

TIEFENBACHER GROUP and OnDosis are thrilled to announce the launch of OYSTA®. The new healthcare brand represents the cooperation initiated in September 2020, including the co-development portfolio of innovative...

Tiefenbacher Group - An older man with gray hair, wearing a yellow long-sleeve shirt and backpack, walks in a lush riverside landscape. In the corner, the logo and text read "AET TIEFENBACHER PHARMACEUTICALS," a family-owned pharmaceutical company.
  • News

Tiefenbacher Pharmaceuticals New Market Launch: Apixaban anticoagulant

New Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the anticoagulant medicine Apixaban in CanadaWe at Tiefenbacher Pharmaceuticals are driven by enabling people around the world a better...

Tiefenbacher Group - Exhibition hall at CPHI 2022 in Frankfurt, featuring the Tiefenbacher Group booth—a family-owned pharmaceutical company specializing in finished dosage forms and API distribution. Bright lighting and displays create a lively atmosphere.
  • News

Meet TIEFENBACHER GROUP at CPhI 2022 in Frankfurt /Germany

Meet TIEFENBACHER GROUP at CPhI in Frankfurt from 1-3 Nov and discover our latest ideas to make pharmaceuticals more affordable, more available, and better than before!We are very excited...

Tiefenbacher Group - A young child dressed as a doctor smiles and lifts glasses. Text reads: “Looking forward to see you at BePharma | B2B Pharmaceutical Networking, October 10–12, 2022, Mexico City. Pioneering Healthcare. Tiefenbacher Group, a family-owned pharmaceutical company.”.
  • News

Meet TIEFENBACHER GROUP at BePharma in Mexico City 2022 from October 10-12!

Meet TIEFENBACHER GROUP at BePharma in Mexico City 2022 from October 10-12!Reach out to AET – Tiefenbacher Group at BePharma the most important Pharma B2B Event in Latin America...

Tiefenbacher Group - Two older women smiling and hugging outdoors, both appearing joyful. The logo and text “AET TIEFENBACHER PHARMACEUTICALS” is visible in the top left corner, highlighting patient-centric drug development.
  • News

Tiefenbacher Pharmaceuticals New Market Launch: Vildagliptin/Metformin

NEW Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the diabetes medicine Vildagliptin and Vildagliptin /Metformin in AfricaWe at Tiefenbacher Pharmaceuticals strive to make our high-quality medicines available...

Get in touch